Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Lycium barbarum (Zeaxanthin dipalmitate).
Zeaxanthin dipalmitate acts as a highly lipophilic macular carotenoid ester that selectively accumulates in the fovea centralis to attenuate photo-oxidative damage and enhance visual acuity via blue-light filtration.
5281250
1045.7 g/mol
26.7
[(1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hexadecanoyloxy-2,6,6-trimethylcyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-yl] hexadecanoate
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Lycium barbarum (Zeaxanthin dipalmitate) across standard consumer modalities.
The high susceptibility of carotenoid esters to photo-oxidation and thermal degradation necessitates the use of opaque capsule shells and nitrogen-purged filling environments.
Incorporating hydrophobic zeaxanthin dipalmitate into a hydrophilic pectin matrix risks lipid migration and surface sweating, potentially compromising shelf-life stability.
The significant molecular weight and required therapeutic dosage of zeaxanthin dipalmitate exceed the typical 20-40mg payload capacity of thin-film polymer matrices.
Ready to launch a product featuring Lycium barbarum (Zeaxanthin dipalmitate)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Lycium barbarum (Zeaxanthin dipalmitate) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Lycium barbarum (Zeaxanthin dipalmitate) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation